EUCTR2004-004899-36-DK进行中（未招募）1 期
Clinical evaluation of the 3 allergens: Methyldibromoglutharonitrile, Parthenolide and Goldsodiumthiosulphate for TRUE Test Panel 3 - a phase II, dose-response study.
Mekos Laboratories0 个研究点目标入组 60 人开始时间: 2005年1月4日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Positive MDBGN patch test within the latest 5 years or positive Parthenolide patch test within the latest 5 years or positive Goldnatriumthiosulphate patch test within the latest 5 years.
- •2. Age more than or equal to 18 years.
- •3. Signed informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.Topical treatment with corticosteroids or immunosuppressives during the latest 7 days on the test area or near the test area.
- •2.Systemic treatment with corticosteroids or immunosuppressives during the latest 7 days.
- •4.Treatment with UV-light during the latest 3 weeks.
- •5.Widespread active dermatitis or dermatitis on test area.
- •6.Breast-feeding, pregnancy or insufficient contraception.If any doubt a negative urine-pregnancy test should be demonstrated or the test should be postponed.
- •7.Subjects not able to cooperate.
- •8.Participation in other clinical studies during the study period and 3 weeks prior to study start.
研究者
相似试验
进行中（未招募）
不适用
Clinical evaluation of the 3 allergens: Methyldibromoglutharonitrile, Parthenolide and Goldsodiumthiosulphate for TRUE Test Panel 3 - a phase II, dose-response study.Diagnosis of Allergic Contact Dermatitis.EUCTR2004-004899-36-SEMekos Laboratories60
已完成
4 期
Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone10017977constipationNL-OMON39494Vrije Universiteit Medisch Centrum195
进行中（未招募）
不适用
Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexoneEUCTR2012-000850-75-NLVU University Medical Center
已完成
4 期
A clinical trial to compare the effect of methylphenidate and atomoxetine in children with attention deficit hyperactivity disorderCTRI/2011/08/001981Department of Psychiatry69
已完成
2 期
An assessment about impression of oral Methylnaltrexone on time of beginning of the bowel sounds after abdominal hysterectomyPostprocedural disorders of genitourinary system, not elsewhere classified.Postprocedural disorder of genitourinary system, unspecifiedIRCT201104121946N8Vice Chancellor for research-Guilan University of Medical Sciences66